Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.
This clinical trial update discusses interhospital variability in programs designed to prevent axillary lymphadenectomy sequelae in breast c…
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. [Phase 4]
Phase 4 clinical trial evaluating whether a PET/CT imaging agent (18F-ALF-NOTA-PRGD2) can predict efficacy and adverse events of apatinib in…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Intraoperative Radiotherapy for Korean Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial update on intraoperative radiotherapy for breast cancer in Korean patients.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women [Phase 2]
Phase 2 clinical trial update evaluating neoadjuvant trastuzumab and letrozole in postmenopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Vitamin D3 for Aromatase Inhibitor Induced Arthralgias [Phase 2]
Phase 2 trial evaluating vitamin D3 for arthralgia associated with aromatase inhibitor therapy in breast cancer patients; study completed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer [Phase 2]
Pfizer reported Phase 2 trial results evaluating the combination of enzalutamide and exemestane in advanced breast cancer, focusing on effic…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update evaluating maintenance and revised regimens for advanced breast cancer survivors after first-line salvage the…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity [Phase 3]
Phase 3 trial evaluating carvedilol to prevent chemotherapy-induced cardiotoxicity in patients with breast cancer and heart failure.
-
CLINICAL_TRIALS withdrawal · 2018-02-05Clinical Trial Update: Iterative PICC Placement Versus Long Term Device [Phase 3]
A Phase 3 clinical trial comparing iterative PICC placement vs long-term device for breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Neoadjuvant Propanolol in Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial of propranolol in breast cancer was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED) [Phase 2]
Phase 2 trial evaluating an experimental drug in women with breast cancer and metastatic bone disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer [Phase 2]
Phase 2 trial update for pyrotinib in metastatic HER2 non-amplified but HER2-mutant breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluated abemaciclib (LY2835219) in postmenopausal women with hormone receptor-positive, HER2-negative breast c…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients [Phase 4]
Phase 4 clinical trial update evaluating Contura Catheter in intermediate-risk, early-stage breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients [Phase 4]
Phase 4 trial update on using the Contura catheter for accelerated partial breast irradiation in low-risk breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02) [Phase 3]
Phase 3 trial evaluating PF-05280014 (trastuzumab-Pfizer) or trastuzumab-EU with paclitaxel for first-line HER2-positive metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) [Phase 2]
Phase 2 trial evaluating intratumoral Hiltonol (poly-ICLC) for solid tumors was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) [Phase 3]
Phase 3 trial comparing S1 generic with capecitabine in metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing docetaxel plus fulvestrant versus docetaxel alone in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Clinical trial update about a breath test used in women receiving tamoxifen for breast cancer prevention or treatment; the study was termina…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. [Phase 3]
Phase 3 trial comparing pegfilgrastim-gema to pegfilgrastim-roche for prevention of induced neutropenia in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial on individualized treatment for locally advanced breast cancer based on tumor molecular characteristic…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab plus irinotecan in HER2-positive metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer [Phase 2]
Phase 2 prospective multicenter observational trial evaluating apatinib alone or with capecitabine for metastatic HER2-negative breast cance…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Neoadjuvant Endocrine Therapy in Breast Cancer [Phase 2]
A Phase 2 trial update evaluating neoadjuvant endocrine therapy in highly endocrine-responsive operable breast cancer has completed.